• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    Antibody De Novo Sequencing: Advances in Mass Spectrometry

      Antibody de novo sequencing is the process of determining the amino acid sequence of an antibody purely through the analysis of the antibody protein itself, without relying on known genetic sequence templates. Mass spectrometry is central to this process. Advances in mass spectrometry, such as the ethcd fragmentation mode in eclipse mass spectrometry, enable the differentiation of leucine (Leu) and isoleucine (Ile) through neutral losses of 43Da and 29Da from their side chains, respectively. This development overcomes the long-standing challenge of distinguishing between Leu and Ile in antibody sequencing. Modern mass spectrometers, with heightened resolution and sensitivity, not only provide accurate amino acid sequences but also detect antibody diversity, including post-translational modifications like glycosylation and phosphorylation. Due to the complexity of antibody structures, traditional sequencing methods often fail to fully resolve amino acid sequences. In this context, antibody de novo sequencing has emerged as a method that provides precise and detailed structural insights by thoroughly analyzing the amino acid sequences of antibodies. This technology is instrumental for researchers and pharmaceutical developers to comprehend the exact structure of antibodies. Since an antibody's amino acid sequence directly influences its function and performance, de novo sequencing allows scientists to identify variable regions, improving the affinity and specificity of antibodies, thus enhancing drug efficacy and safety. Additionally, antibody de novo sequencing is crucial for monitoring the consistency and stability of antibody drugs during manufacturing to ensure they meet quality standards.

       

      Common Methods

      1. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

      This method combines the separation capacity of liquid chromatography with the sensitivity of mass spectrometry, effectively analyzing antibody amino acid sequences. LC-MS/MS offers high throughput and accuracy, delivering detailed sequence information swiftly.

       

      2. High-Resolution Mass Spectrometry

      Utilizing high-precision instruments, this method determines amino acid sequences through exact mass measurements. It is suitable for complex antibody molecules and provides highly reliable results.

       

      Technical Process

      The antibody de novo sequencing process involves sample preparation, enzymatic digestion, mass spectrometry analysis, and data interpretation. Initially, antibody samples are purified to eliminate impurities and then enzymatically broken down into smaller peptides. These peptides undergo mass spectrometry analysis, and bioinformatics approaches are employed to interpret the data and derive the complete amino acid sequence.

       

      Considerations

      Sample purity and quality control are critical in antibody de novo sequencing as impurities can compromise mass spectrometry accuracy. During enzymatic digestion, selecting the appropriate enzymes and conditions is essential for full antibody breakdown. Challenges often encountered include weak mass spectrometry signals, limited sequence coverage, and data interpretation difficulties. Weak signals may result from low sample purity or instrument sensitivity, while insufficient sequence coverage can be addressed by optimizing digestion conditions and increasing analysis repetitions.

       

      The primary benefits of antibody de novo sequencing are its complete and precise resolution capabilities, providing full sequence information and identifying potential variations. Its high-throughput nature also allows for the processing of numerous samples rapidly, meeting modern research and drug development demands. MtoZ Biolabs offers advanced antibody de novo sequencing services, backed by cutting-edge technology and an expert team, delivering efficient and precise sequencing solutions. We are dedicated to resolving challenges in antibody development and have earned widespread trust internationally.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

      Antibody De Novo Sequencing Service

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png